RepliCel Life Sciences Inc.
General ticker "REPCF" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $180.4K (TTM average)
RepliCel Life Sciences Inc. does not follow the US Stock Market performance with the rate: -7.9%.
Estimated limits based on current volatility of 0.0%: low 0.00$, high 0.00$
Short-term REPCF quotes
Long-term REPCF plot
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | CA$0.35MM |
| Operating Expenses | CA$1.74MM |
| Operating Income | CA$-1.39MM |
| Non-Operating Income | CA$1.07MM |
| Interest Expense | CA$0.15MM |
| R&D Expense | CA$0.53MM |
| Income(Loss) | CA$-0.31MM |
| Profit(Loss)* | CA$-0.31MM |
| Stockholders Equity | CA$-4.53MM |
| Assets | CA$0.29MM |
| Operating Cash Flow | CA$-1.41MM |
| Financing Cash Flow | CA$1.06MM |
| Earnings Per Share** | CA$-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.